XML 69 R50.htm IDEA: XBRL DOCUMENT v3.21.1
Segments of Business and Geographic Areas - Sales By Segment Of Business (Details) - USD ($)
$ in Millions
 3 Months Ended
Apr. 04, 2021
Mar. 29, 2020
Sales by segment of business    
Sales to customers $ 22,321 $ 20,691
Percent Change (as a percent) 7.90%  
U.S.    
Sales by segment of business    
Sales to customers $ 11,111 10,699
Percent Change (as a percent) 3.90%  
International    
Sales by segment of business    
Sales to customers $ 11,210 9,992
Percent Change (as a percent) 12.20%  
Consumer Health    
Sales by segment of business    
Sales to customers $ 3,543 3,625
Percent Change (as a percent) (2.30%)  
Consumer Health | U.S.    
Sales by segment of business    
Sales to customers $ 1,611 1,740
Percent Change (as a percent) (7.40%)  
Consumer Health | International    
Sales by segment of business    
Sales to customers $ 1,932 1,885
Percent Change (as a percent) 2.50%  
Consumer Health | OTC    
Sales by segment of business    
Sales to customers $ 1,175 1,348
Percent Change (as a percent) (12.90%)  
Consumer Health | OTC | U.S.    
Sales by segment of business    
Sales to customers $ 599 689
Percent Change (as a percent) (13.00%)  
Consumer Health | OTC | International    
Sales by segment of business    
Sales to customers $ 575 659
Percent Change (as a percent) (12.80%)  
Consumer Health | Skin Health/Beauty    
Sales by segment of business    
Sales to customers $ 1,163 1,117
Percent Change (as a percent) 4.10%  
Consumer Health | Skin Health/Beauty | U.S.    
Sales by segment of business    
Sales to customers $ 634 659
Percent Change (as a percent) (3.90%)  
Consumer Health | Skin Health/Beauty | International    
Sales by segment of business    
Sales to customers $ 529 458
Percent Change (as a percent) 15.70%  
Consumer Health | Oral Care    
Sales by segment of business    
Sales to customers $ 417 395
Percent Change (as a percent) 5.70%  
Consumer Health | Oral Care | U.S.    
Sales by segment of business    
Sales to customers $ 163 176
Percent Change (as a percent) (7.20%)  
Consumer Health | Oral Care | International    
Sales by segment of business    
Sales to customers $ 254 219
Percent Change (as a percent) 16.00%  
Consumer Health | Baby Care    
Sales by segment of business    
Sales to customers $ 389 361
Percent Change (as a percent) 7.70%  
Consumer Health | Baby Care | U.S.    
Sales by segment of business    
Sales to customers $ 96 92
Percent Change (as a percent) 4.20%  
Consumer Health | Baby Care | International    
Sales by segment of business    
Sales to customers $ 293 269
Percent Change (as a percent) 8.90%  
Consumer Health | Women's Health    
Sales by segment of business    
Sales to customers $ 222 232
Percent Change (as a percent) (4.30%)  
Consumer Health | Women's Health | U.S.    
Sales by segment of business    
Sales to customers $ 3 4
Percent Change (as a percent) (25.80%)  
Consumer Health | Women's Health | International    
Sales by segment of business    
Sales to customers $ 219 228
Percent Change (as a percent) (3.90%)  
Consumer Health | Wound Care/Other    
Sales by segment of business    
Sales to customers $ 177 171
Percent Change (as a percent) 3.30%  
Consumer Health | Wound Care/Other | U.S.    
Sales by segment of business    
Sales to customers $ 115 119
Percent Change (as a percent) (3.00%)  
Consumer Health | Wound Care/Other | International    
Sales by segment of business    
Sales to customers $ 61 52
Percent Change (as a percent) 17.60%  
PHARMACEUTICAL    
Sales by segment of business    
Sales to customers $ 12,199 11,134
Percent Change (as a percent) 9.60%  
PHARMACEUTICAL | U.S.    
Sales by segment of business    
Sales to customers $ 6,446 6,061
Percent Change (as a percent) 6.40%  
PHARMACEUTICAL | International    
Sales by segment of business    
Sales to customers $ 5,753 5,073
Percent Change (as a percent) 13.40%  
PHARMACEUTICAL | Immunology    
Sales by segment of business    
Sales to customers $ 3,914 3,638
Percent Change (as a percent) 7.60%  
PHARMACEUTICAL | Immunology | U.S.    
Sales by segment of business    
Sales to customers $ 2,413 2,410
Percent Change (as a percent) 0.10%  
PHARMACEUTICAL | Immunology | International    
Sales by segment of business    
Sales to customers $ 1,501 1,228
Percent Change (as a percent) 22.30%  
PHARMACEUTICAL | Immunology | REMICADE®    
Sales by segment of business    
Sales to customers $ 777 990
Percent Change (as a percent) (21.50%)  
PHARMACEUTICAL | Immunology | REMICADE® | U.S.    
Sales by segment of business    
Sales to customers $ 489 625
Percent Change (as a percent) (21.70%)  
PHARMACEUTICAL | Immunology | REMICADE® | U.S. Exports    
Sales by segment of business    
Sales to customers $ 57 110
Percent Change (as a percent) (48.40%)  
PHARMACEUTICAL | Immunology | REMICADE® | International    
Sales by segment of business    
Sales to customers $ 232 256
Percent Change (as a percent) (9.40%)  
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA®    
Sales by segment of business    
Sales to customers $ 562 529
Percent Change (as a percent) 6.20%  
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA® | U.S.    
Sales by segment of business    
Sales to customers $ 255 272
Percent Change (as a percent) (5.90%)  
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA® | International    
Sales by segment of business    
Sales to customers $ 307 258
Percent Change (as a percent) 18.90%  
PHARMACEUTICAL | Immunology | STELARA®    
Sales by segment of business    
Sales to customers $ 2,148 1,819
Percent Change (as a percent) 18.10%  
PHARMACEUTICAL | Immunology | STELARA® | U.S.    
Sales by segment of business    
Sales to customers $ 1,331 1,217
Percent Change (as a percent) 9.40%  
PHARMACEUTICAL | Immunology | STELARA® | International    
Sales by segment of business    
Sales to customers $ 817 603
Percent Change (as a percent) 35.60%  
PHARMACEUTICAL | Immunology | TREMFYA®    
Sales by segment of business    
Sales to customers $ 418 296
Percent Change (as a percent) 41.00%  
PHARMACEUTICAL | Immunology | TREMFYA® | U.S.    
Sales by segment of business    
Sales to customers $ 274 187
Percent Change (as a percent) 46.30%  
PHARMACEUTICAL | Immunology | TREMFYA® | International    
Sales by segment of business    
Sales to customers $ 143 109
Percent Change (as a percent) 32.00%  
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY    
Sales by segment of business    
Sales to customers $ 8 3
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY | U.S.    
Sales by segment of business    
Sales to customers 7 0
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY | International    
Sales by segment of business    
Sales to customers $ 2 3
Percent Change (as a percent) (38.40%)  
PHARMACEUTICAL | Infectious Diseases    
Sales by segment of business    
Sales to customers $ 1,007 920
Percent Change (as a percent) 9.50%  
PHARMACEUTICAL | Infectious Diseases | U.S.    
Sales by segment of business    
Sales to customers $ 512 436
Percent Change (as a percent) 17.40%  
PHARMACEUTICAL | Infectious Diseases | International    
Sales by segment of business    
Sales to customers $ 494 483
Percent Change (as a percent) 2.30%  
PHARMACEUTICAL | Infectious Diseases | COVID-19    
Sales by segment of business    
Sales to customers $ 100 0
PHARMACEUTICAL | Infectious Diseases | COVID-19 | U.S.    
Sales by segment of business    
Sales to customers 100 0
PHARMACEUTICAL | Infectious Diseases | COVID-19 | International    
Sales by segment of business    
Sales to customers 0 0
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine    
Sales by segment of business    
Sales to customers $ 243 224
Percent Change (as a percent) 8.60%  
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine | U.S.    
Sales by segment of business    
Sales to customers $ 10 12
Percent Change (as a percent) (12.30%)  
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine | International    
Sales by segment of business    
Sales to customers $ 233 212
Percent Change (as a percent) 9.80%  
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA®    
Sales by segment of business    
Sales to customers $ 546 579
Percent Change (as a percent) (5.80%)  
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA® | U.S.    
Sales by segment of business    
Sales to customers $ 380 396
Percent Change (as a percent) (3.80%)  
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA® | International    
Sales by segment of business    
Sales to customers $ 166 184
Percent Change (as a percent) (9.90%)  
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES    
Sales by segment of business    
Sales to customers $ 117 116
Percent Change (as a percent) 0.60%  
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES | U.S.    
Sales by segment of business    
Sales to customers $ 21 29
Percent Change (as a percent) (27.00%)  
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES | International    
Sales by segment of business    
Sales to customers $ 96 87
Percent Change (as a percent) 9.70%  
PHARMACEUTICAL | Neuroscience    
Sales by segment of business    
Sales to customers $ 1,721 1,658
Percent Change (as a percent) 3.80%  
PHARMACEUTICAL | Neuroscience | U.S.    
Sales by segment of business    
Sales to customers $ 771 748
Percent Change (as a percent) 3.20%  
PHARMACEUTICAL | Neuroscience | International    
Sales by segment of business    
Sales to customers $ 949 910
Percent Change (as a percent) 4.30%  
PHARMACEUTICAL | Neuroscience | CONCERTA® / methylphenidate    
Sales by segment of business    
Sales to customers $ 171 171
Percent Change (as a percent) 0.20%  
PHARMACEUTICAL | Neuroscience | CONCERTA® / methylphenidate | U.S.    
Sales by segment of business    
Sales to customers $ 47 52
Percent Change (as a percent) (9.60%)  
PHARMACEUTICAL | Neuroscience | CONCERTA® / methylphenidate | International    
Sales by segment of business    
Sales to customers $ 123 118
Percent Change (as a percent) 4.50%  
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / INVEGA TRINZA® / TREVICTA®    
Sales by segment of business    
Sales to customers $ 965 883
Percent Change (as a percent) 9.40%  
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / INVEGA TRINZA® / TREVICTA® | U.S.    
Sales by segment of business    
Sales to customers $ 589 544
Percent Change (as a percent) 8.30%  
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / INVEGA TRINZA® / TREVICTA® | International    
Sales by segment of business    
Sales to customers $ 376 339
Percent Change (as a percent) 11.00%  
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA®    
Sales by segment of business    
Sales to customers $ 157 170
Percent Change (as a percent) (7.90%)  
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA® | U.S.    
Sales by segment of business    
Sales to customers $ 67 76
Percent Change (as a percent) (11.80%)  
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA® | International    
Sales by segment of business    
Sales to customers $ 89 94
Percent Change (as a percent) (4.80%)  
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE    
Sales by segment of business    
Sales to customers $ 428 435
Percent Change (as a percent) (1.50%)  
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE | U.S.    
Sales by segment of business    
Sales to customers $ 67 75
Percent Change (as a percent) (9.80%)  
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE | International    
Sales by segment of business    
Sales to customers $ 361 360
Percent Change (as a percent) 0.20%  
PHARMACEUTICAL | Oncology    
Sales by segment of business    
Sales to customers $ 3,570 3,013
Percent Change (as a percent) 18.50%  
PHARMACEUTICAL | Oncology | U.S.    
Sales by segment of business    
Sales to customers $ 1,377 1,175
Percent Change (as a percent) 17.20%  
PHARMACEUTICAL | Oncology | International    
Sales by segment of business    
Sales to customers $ 2,193 1,839
Percent Change (as a percent) 19.30%  
PHARMACEUTICAL | Oncology | DARZALEX®    
Sales by segment of business    
Sales to customers $ 1,365 937
Percent Change (as a percent) 45.60%  
PHARMACEUTICAL | Oncology | DARZALEX® | U.S.    
Sales by segment of business    
Sales to customers $ 691 463
Percent Change (as a percent) 49.20%  
PHARMACEUTICAL | Oncology | DARZALEX® | International    
Sales by segment of business    
Sales to customers $ 674 474
Percent Change (as a percent) 42.20%  
PHARMACEUTICAL | Oncology | ERLEADA    
Sales by segment of business    
Sales to customers $ 261 143
Percent Change (as a percent) 82.80%  
PHARMACEUTICAL | Oncology | ERLEADA | U.S.    
Sales by segment of business    
Sales to customers $ 171 119
Percent Change (as a percent) 44.00%  
PHARMACEUTICAL | Oncology | ERLEADA | International    
Sales by segment of business    
Sales to customers $ 90 24
PHARMACEUTICAL | Oncology | IMBRUVICA®    
Sales by segment of business    
Sales to customers $ 1,125 1,031
Percent Change (as a percent) 9.00%  
PHARMACEUTICAL | Oncology | IMBRUVICA® | U.S.    
Sales by segment of business    
Sales to customers $ 444 432
Percent Change (as a percent) 2.80%  
PHARMACEUTICAL | Oncology | IMBRUVICA® | International    
Sales by segment of business    
Sales to customers $ 680 599
Percent Change (as a percent) 13.50%  
PHARMACEUTICAL | Oncology | ZYTIGA® / abiraterone acetate    
Sales by segment of business    
Sales to customers $ 638 690
Percent Change (as a percent) (7.60%)  
PHARMACEUTICAL | Oncology | ZYTIGA® / abiraterone acetate | U.S.    
Sales by segment of business    
Sales to customers $ 50 139
Percent Change (as a percent) (64.20%)  
PHARMACEUTICAL | Oncology | ZYTIGA® / abiraterone acetate | International    
Sales by segment of business    
Sales to customers $ 588 552
Percent Change (as a percent) 6.60%  
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY(1)    
Sales by segment of business    
Sales to customers $ 182 212
Percent Change (as a percent) (14.20%)  
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY(1) | U.S.    
Sales by segment of business    
Sales to customers $ 21 22
Percent Change (as a percent) (5.10%)  
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY(1) | International    
Sales by segment of business    
Sales to customers $ 161 190
Percent Change (as a percent) (15.30%)  
PHARMACEUTICAL | Pulmonary Hypertension    
Sales by segment of business    
Sales to customers $ 861 745
Percent Change (as a percent) 15.50%  
PHARMACEUTICAL | Pulmonary Hypertension | U.S.    
Sales by segment of business    
Sales to customers $ 573 486
Percent Change (as a percent) 18.00%  
PHARMACEUTICAL | Pulmonary Hypertension | International    
Sales by segment of business    
Sales to customers $ 288 260
Percent Change (as a percent) 10.80%  
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT®    
Sales by segment of business    
Sales to customers $ 450 389
Percent Change (as a percent) 15.60%  
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT® | U.S.    
Sales by segment of business    
Sales to customers $ 272 229
Percent Change (as a percent) 18.50%  
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT® | International    
Sales by segment of business    
Sales to customers $ 179 160
Percent Change (as a percent) 11.50%  
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI®    
Sales by segment of business    
Sales to customers $ 305 250
Percent Change (as a percent) 22.00%  
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI® | U.S.    
Sales by segment of business    
Sales to customers $ 259 212
Percent Change (as a percent) 21.90%  
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI® | International    
Sales by segment of business    
Sales to customers $ 46 38
Percent Change (as a percent) 23.00%  
PHARMACEUTICAL | Pulmonary Hypertension | Other    
Sales by segment of business    
Sales to customers $ 105 106
Percent Change (as a percent) (0.60%)  
PHARMACEUTICAL | Pulmonary Hypertension | Other | U.S.    
Sales by segment of business    
Sales to customers $ 42 44
Percent Change (as a percent) (3.50%)  
PHARMACEUTICAL | Pulmonary Hypertension | Other | International    
Sales by segment of business    
Sales to customers $ 63 62
Percent Change (as a percent) 1.40%  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other    
Sales by segment of business    
Sales to customers $ 1,127 1,160
Percent Change (as a percent) (2.80%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | U.S.    
Sales by segment of business    
Sales to customers $ 799 806
Percent Change (as a percent) (0.90%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | International    
Sales by segment of business    
Sales to customers $ 328 354
Percent Change (as a percent) (7.20%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO®    
Sales by segment of business    
Sales to customers $ 589 527
Percent Change (as a percent) 11.70%  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO® | U.S.    
Sales by segment of business    
Sales to customers $ 589 527
Percent Change (as a percent) 11.70%  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO® | International    
Sales by segment of business    
Sales to customers $ 0 0
Percent Change (as a percent) 0.00%  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET®    
Sales by segment of business    
Sales to customers $ 150 175
Percent Change (as a percent) (14.40%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET® | U.S.    
Sales by segment of business    
Sales to customers $ 87 117
Percent Change (as a percent) (26.10%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET® | International    
Sales by segment of business    
Sales to customers $ 63 58
Percent Change (as a percent) 9.20%  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX®    
Sales by segment of business    
Sales to customers $ 127 155
Percent Change (as a percent) (18.20%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX® | U.S.    
Sales by segment of business    
Sales to customers $ 62 76
Percent Change (as a percent) (18.30%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX® | International    
Sales by segment of business    
Sales to customers $ 64 79
Percent Change (as a percent) (18.10%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | Other    
Sales by segment of business    
Sales to customers $ 261 302
Percent Change (as a percent) (13.60%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | Other | U.S.    
Sales by segment of business    
Sales to customers $ 60 85
Percent Change (as a percent) (28.80%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | Other | International    
Sales by segment of business    
Sales to customers $ 201 217
Percent Change (as a percent) (7.70%)  
MEDICAL DEVICES    
Sales by segment of business    
Sales to customers $ 6,579 5,932
Percent Change (as a percent) 10.90%  
MEDICAL DEVICES | U.S.    
Sales by segment of business    
Sales to customers $ 3,054 2,898
Percent Change (as a percent) 5.40%  
MEDICAL DEVICES | International    
Sales by segment of business    
Sales to customers $ 3,525 3,034
Percent Change (as a percent) 16.20%  
MEDICAL DEVICES | Interventional Solutions    
Sales by segment of business    
Sales to customers $ 949 727
Percent Change (as a percent) 30.40%  
MEDICAL DEVICES | Interventional Solutions | U.S.    
Sales by segment of business    
Sales to customers $ 434 365
Percent Change (as a percent) 19.00%  
MEDICAL DEVICES | Interventional Solutions | International    
Sales by segment of business    
Sales to customers $ 514 362
Percent Change (as a percent) 42.00%  
MEDICAL DEVICES | Orthopaedics    
Sales by segment of business    
Sales to customers $ 2,113 2,038
Percent Change (as a percent) 3.70%  
MEDICAL DEVICES | Orthopaedics | U.S.    
Sales by segment of business    
Sales to customers $ 1,249 1,250
Percent Change (as a percent) (0.10%)  
MEDICAL DEVICES | Orthopaedics | International    
Sales by segment of business    
Sales to customers $ 864 788
Percent Change (as a percent) 9.70%  
MEDICAL DEVICES | Orthopaedics | HIPS    
Sales by segment of business    
Sales to customers $ 357 337
Percent Change (as a percent) 5.80%  
MEDICAL DEVICES | Orthopaedics | HIPS | U.S.    
Sales by segment of business    
Sales to customers $ 210 206
Percent Change (as a percent) 2.40%  
MEDICAL DEVICES | Orthopaedics | HIPS | International    
Sales by segment of business    
Sales to customers $ 146 132
Percent Change (as a percent) 11.20%  
MEDICAL DEVICES | Orthopaedics | KNEES    
Sales by segment of business    
Sales to customers $ 317 343
Percent Change (as a percent) (7.60%)  
MEDICAL DEVICES | Orthopaedics | KNEES | U.S.    
Sales by segment of business    
Sales to customers $ 185 214
Percent Change (as a percent) (13.50%)  
MEDICAL DEVICES | Orthopaedics | KNEES | International    
Sales by segment of business    
Sales to customers $ 132 130
Percent Change (as a percent) 2.00%  
MEDICAL DEVICES | Orthopaedics | TRAUMA    
Sales by segment of business    
Sales to customers $ 733 654
Percent Change (as a percent) 12.10%  
MEDICAL DEVICES | Orthopaedics | TRAUMA | U.S.    
Sales by segment of business    
Sales to customers $ 450 407
Percent Change (as a percent) 10.70%  
MEDICAL DEVICES | Orthopaedics | TRAUMA | International    
Sales by segment of business    
Sales to customers $ 282 247
Percent Change (as a percent) 14.40%  
MEDICAL DEVICES | Orthopaedics | SPINE, SPORTS & OTHER    
Sales by segment of business    
Sales to customers $ 706 703
Percent Change (as a percent) 0.40%  
MEDICAL DEVICES | Orthopaedics | SPINE, SPORTS & OTHER | U.S.    
Sales by segment of business    
Sales to customers $ 403 423
Percent Change (as a percent) (4.80%)  
MEDICAL DEVICES | Orthopaedics | SPINE, SPORTS & OTHER | International    
Sales by segment of business    
Sales to customers $ 303 280
Percent Change (as a percent) 8.40%  
MEDICAL DEVICES | Surgery    
Sales by segment of business    
Sales to customers $ 2,372 2,100
Percent Change (as a percent) 12.90%  
MEDICAL DEVICES | Surgery | U.S.    
Sales by segment of business    
Sales to customers $ 898 844
Percent Change (as a percent) 6.50%  
MEDICAL DEVICES | Surgery | International    
Sales by segment of business    
Sales to customers $ 1,474 1,257
Percent Change (as a percent) 17.30%  
MEDICAL DEVICES | Surgery | ADVANCED    
Sales by segment of business    
Sales to customers $ 1,118 948
Percent Change (as a percent) 18.00%  
MEDICAL DEVICES | Surgery | ADVANCED | U.S.    
Sales by segment of business    
Sales to customers $ 405 381
Percent Change (as a percent) 6.50%  
MEDICAL DEVICES | Surgery | ADVANCED | International    
Sales by segment of business    
Sales to customers $ 713 567
Percent Change (as a percent) 25.70%  
MEDICAL DEVICES | Surgery | GENERAL    
Sales by segment of business    
Sales to customers $ 1,254 1,153
Percent Change (as a percent) 8.80%  
MEDICAL DEVICES | Surgery | GENERAL | U.S.    
Sales by segment of business    
Sales to customers $ 493 463
Percent Change (as a percent) 6.50%  
MEDICAL DEVICES | Surgery | GENERAL | International    
Sales by segment of business    
Sales to customers $ 761 690
Percent Change (as a percent) 10.30%  
MEDICAL DEVICES | Vision    
Sales by segment of business    
Sales to customers $ 1,145 1,067
Percent Change (as a percent) 7.30%  
MEDICAL DEVICES | Vision | U.S.    
Sales by segment of business    
Sales to customers $ 472 439
Percent Change (as a percent) 7.40%  
MEDICAL DEVICES | Vision | International    
Sales by segment of business    
Sales to customers $ 673 628
Percent Change (as a percent) 7.30%  
MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER    
Sales by segment of business    
Sales to customers $ 857 814
Percent Change (as a percent) 5.30%  
MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER | U.S.    
Sales by segment of business    
Sales to customers $ 371 346
Percent Change (as a percent) 7.20%  
MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER | International    
Sales by segment of business    
Sales to customers $ 486 467
Percent Change (as a percent) 4.00%  
MEDICAL DEVICES | Vision | SURGICAL    
Sales by segment of business    
Sales to customers $ 288 253
Percent Change (as a percent) 13.70%  
MEDICAL DEVICES | Vision | SURGICAL | U.S.    
Sales by segment of business    
Sales to customers $ 101 93
Percent Change (as a percent) 8.20%  
MEDICAL DEVICES | Vision | SURGICAL | International    
Sales by segment of business    
Sales to customers $ 187 $ 160
Percent Change (as a percent) 17.00%